Human medicines European public assessment report (EPAR): Fabrazyme, agalsidase beta, Fabry Disease, Date of authorisation: 03/08/2001, Revision: 26, Status: Authorised
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):